Olux: Foam - Hydroalcoholic (0.05%)

Detailed Information

ON THIS PAGE:
What is this Medicine?
CVS Patient Statistics
In-Depth Information
Learn More
Patient Experiences

Also see:

Get answers to Frequently Asked Questions (FAQs)
Find other class related drugs
Find additional patient usage statistics

Visit Drug Summary Page

Check Drug Interactions

Refill Prescription Transfer Prescription

Olux 0.05% Topical Foam

What is this Medicine?

CLOBETASOL (kloe BAY ta sol) is a corticosteroid. It is used on the skin to treat itching, redness, and swelling caused by some skin conditions.

Similar Generic Drugs : Clobetasol: Foam - Hydroalcoholic (0.05%)

CVS Pharmacy Patient Statistics for Olux: Foam - Hydroalcoholic(0.05%)

Generic vs. Brand Name Usage*

*Brand contains same active ingredient but may not represent FDA-approved generic equivalent

Usage By Strength

In-Depth Information

Select a Medication

Olux 0.05% Topical Foam

NDC: 400760031

Prescription Required
Not a Controlled Drug
(CSA Schedule)
FDA Approved

FDA approved for the following conditions:
Contact Dermatitis, Keloids, Urticaria, Alopecia, Rhus Dermatitis, Necrobiosis Lipoidica Diabeticorum, Eczema, Pemphigus, Sarcoidosis, Discoid Lupus Erythematosus, Granuloma Annulare, Pityriasis Rosea, Psoriasis, Lichen Striatus, Lichen Simplex, Atopic Dermatitis, Lichen Planus, Exfoliative Dermatitis

Storage Information
Flammable, keep away from heat and flame
Do Not Store at Temperatures Above 120 degrees F (49 degrees C)
Store at controlled room temperature (between 68 and 77 degrees F)

Olux 0.05% Topical Foam

Ingredients

Close All Sections

Reported Side Effects for Olux 0.05% Topical Foam

Spider Veins Incidence: <2.0%* Severity: MILD
Onset: DELAYED

Striae Incidence: <2.0%* Severity: MILD
Onset: DELAYED

Sweat Rash Incidence: <2.0%* Severity: MILD
Onset: DELAYED

Ambras Syndrome Incidence: <2.0%* Severity: MILD
Onset: DELAYED

Drug-Induced Acne Incidence: <2.0%* Severity: MILD
Onset: DELAYED

Thinning Of Skin Incidence: <2.0%* Severity: SEVERE
Onset: DELAYED

Inflamed Hair Follicles Incidence: <2.0%* Severity: MILD
Onset: DELAYED

Unusual Skin Lightening Incidence: <2.0%* Severity: MILD
Onset: DELAYED

Infection Incidence: <2.0%* Severity: MILD
Onset: DELAYED

Rash With Pustules Incidence: 1.0-10.0%* Severity: MILD
Onset: EARLY

Itching Incidence: 1.0-10.0%* Severity: MILD
Onset: RAPID

Dry Skin Incidence: 1.0-10.0%* Severity: MILD
Onset: DELAYED

Skin Redness Incidence: 1.0-10.0%* Severity: MODERATE
Onset: EARLY

Skin Irritation Incidence: 2.0-10.0%* Severity: MILD
Onset: EARLY

*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.

Pregnancy & Lactation Information

FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

THIRD Trimester

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.

Learning More About

Visit the Drug Summary page where you can: